Clinical Trials Logo

Clinical Trial Summary

During a previous clinical trial (RCF-abdo: 2018-A01194-51), trans-abdominal signals were collected in 90 patients at the maternity Jeanne de Flandre. This database allowed us to develop a new medical device able to measure in real time and continuously the fetal heart rate and the uterine contractions. The goal here is to assess the performance of the device in real situation during labour. This study will be carried out in the maternity labor ward in CHU Lille, France. The TOCONAUTE will be placed on the mother's abdomen to capture fetal and maternal heart rate as well as the uterine contractions in parallel of the cardiotocograph. For each of the participants, the TOCONAUTE will remain on the mother's abdomen till childbirth. This procedure will not affect the usual care of the patient.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05263427
Study type Interventional
Source University Hospital, Lille
Contact Charles Garabedian, MD,PhD
Phone 0320445962
Email charles.garabedian@chru-lille.fr
Status Recruiting
Phase N/A
Start date August 31, 2022
Completion date August 2024

See also
  Status Clinical Trial Phase
Completed NCT03364491 - Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Phase 3
Recruiting NCT03487185 - Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy N/A